GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Options Update: How to Play Expedia
23:28 - Bay Crest Partners Equity Derivatives Strategist Anshul Agarwal discusses his options play for Expedia. He speaks on “Bloomberg Markets.” (Source: Bloomberg)
  • Ice Hockey's 'Miracle on Ice' Gear Up for Sale
  • STOXX 600 on Course for Best Monthly Gain Since February
  • Fidelity National in Talks to Acquire Sungard for $8.3B